You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cluster of Differentiation 47 (CD47)

Showing 1 - 25 of 7,725
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematological Malignancy, Lymphoma Trial in Canton (SG2501)

Recruiting
  • Hematological Malignancy
  • Lymphoma
  • Canton, Ohio
    Gabrail Cancer Center Research, LLC
Aug 3, 2022

Cancer of the Colon Trial in Marseille (BLOOD AND TUMOR)

Recruiting
  • Cancer of the Colon
  • BLOOD AND TUMOR
  • Marseille, France
    Institut Paoli Calmettes
Jul 12, 2023

Erythema, Rosacea Trial in United States (CD07805/47 gel 0.5%/CD07805/47 Vehicle, azelaic acid gel 15%)

Completed
Has Results
  • Erythema
  • Rosacea
  • CD07805/47 gel 0.5%/CD07805/47 Vehicle
  • azelaic acid gel 15%
  • Evansville, Indiana
  • +3 more
Jul 28, 2022

P47-Phox, Deficiency of Trial in London (Lentiviral vector transduced CD34+ cells)

Not yet recruiting
  • P47-Phox, Deficiency of
  • Lentiviral vector transduced CD34+ cells
  • London, United Kingdom
    Great Ormond Street Hospital
Aug 2, 2022

Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)

Recruiting
  • Neoplasms
  • +2 more
  • RD13-02 cell infusion
  • Xuzhou, Jiangsu, China
    Affiliated hospital of Xuzhou medical college
Jun 7, 2023

Advanced Solid Tumor, NSCLC, Small Cell Lung Cancer Trial (IMM2520)

Not yet recruiting
  • Advanced Solid Tumor
  • +5 more
  • (no location specified)
Mar 20, 2023

Acquired Hemophilia Trial in Tianjin (Daratumumab)

Recruiting
  • Acquired Hemophilia
  • Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
May 5, 2023

Circulating Cluster of Differentiation 4 Positive 28 Null T

Not yet recruiting
  • Autoimmune Hemolytic Anemia
    • (no location specified)
    Jan 31, 2023

    Patients With Recurrent Acute Myelogenous Leukemia After Transplantation Trial in Suzhou (CD47 mAb)

    Recruiting
    • Patients With Recurrent Acute Myelogenous Leukemia After Transplantation
    • CD47 monoclonal antibody
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University, Jiangsu Ins
    Mar 3, 2022

    Ovarian Cancer Trial in Pittsburgh (Pembrolizumab, ALX148, Doxorubicin)

    Not yet recruiting
    • Ovarian Cancer
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jul 19, 2022

    Lymphoma, B-Cell, Lymphoma, Non-hodgkins, Chronic Lymphocytic Leukemia Trial run by the NCI (Anti-cluster of differentiation 19

    Terminated
    Has Results
    • Lymphoma, B-Cell
    • +3 more
    • Anti-cluster of differentiation 19 (CD19)-Chimeric Antigen Receptors (CAR) and Anti-cluster of differentiation 20 (CD20)-CAR T cells
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2022

    Relapsed/Refractory Lymphoma Trial in Beijing (Recombinant humanized anti-CD47/PD-1 bifunctional antibody HX009 injection)

    Recruiting
    • Relapsed/Refractory Lymphoma
    • Recombinant humanized anti-CD47/PD-1 bifunctional antibody HX009 injection
    • Beijing, Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciense
    Jan 10, 2022

    Tumors, Hematologic Tumors, Tumors by Site Trial in Wuhan (RD13-02 cell infusion)

    Recruiting
    • Neoplasms
    • +3 more
    • RD13-02 cell infusion
    • Wuhan, Hubei, China
      Union Hospital, Huazhong University of Science and Technology
    Jun 8, 2023

    Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma Trial (HCB101)

    Not yet recruiting
    • Advanced Solid Tumor
    • Refractory Non-Hodgkin Lymphoma
    • (no location specified)
    May 28, 2023

    T Cell Lymphoma Trial in Kansas City (Brentuximab Vedotin)

    Withdrawn
    • T Cell Lymphoma
    • Brentuximab Vedotin
    • Kansas City, Kansas
      The University of Kansas Cancer Center, Westwood Campus
    Feb 1, 2023

    Resectable Gastric or Gastroesophageal Junction Adenocarcinoma Trial (Cadonilimab, AK117, Oxaliplatin)

    Not yet recruiting
    • Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
    • (no location specified)
    Jul 17, 2023

    HPV 16+ Recurrent or Metastatic Cancer Trial (CD8 reduced peripheral blood cells taken from related donors vaccinated against

    Not yet recruiting
    • HPV 16+ Recurrent or Metastatic Cancer
    • CD8 reduced peripheral blood cells taken from related donors vaccinated against HPV16
    • Non-myeloablative allogeneic bone marrow transplant from related donors vaccinated against HPV16
    • (no location specified)
    Jun 27, 2022

    Pyoderma, Pyoderma Gangrenosum, Pyoderma Vegetans Trial in Minsk, Riga (Monoclonal antibody (Mab) sB24M)

    Active, not recruiting
    • Pyoderma
    • +3 more
    • Monoclonal antibody (Mab) sB24M
    • Minsk, Belarus
    • +1 more
    Jul 8, 2022

    Advanced Solid Tumors Trial in Beijing (HX009)

    Active, not recruiting
    • Advanced Solid Tumors
    • Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciense
    Feb 7, 2023

    Advanced Malignant Tumor Trial in Guangzhou (BAT7104 injection)

    Recruiting
    • Advanced Malignant Tumor
    • BAT7104 injection
    • Guangzhou, Guangdong, China
      Li Zhang
    Mar 1, 2023

    Advanced Malignant Tumors Trial in Hangzhou (AK112, AK117, Chemotherapy)

    Recruiting
    • Advanced Malignant Tumors
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Jan 27, 2022

    Solid Tumor, Non-Hodgkin Lymphoma Trial in Shanghai, Hangzhou (Gentulizumab)

    Recruiting
    • Solid Tumor
    • Non-Hodgkin Lymphoma
    • Shanghai, Shanghai, China
    • +1 more
    Jan 21, 2022

    Myelodysplastic Syndrome Trial in Suzhou (AK117, Azacitidine)

    Recruiting
    • Myelodysplastic Syndrome
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Jul 21, 2021

    Acute Myeloid Leukemia Trial in Hangzhou (AK117, Azacitidine)

    Recruiting
    • Acute Myeloid Leukemia
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital，Zhejiang University School of Medi
    Jul 21, 2021

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, drug, biological, other)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +8 more
    • Duarte, California
      City of Hope Medical Center
    Apr 10, 2023